Fintel reports that on November 18, 2025, B of A Securities maintained coverage of Jazz Pharmaceuticals (NasdaqGS:JAZZ) with ...
Fintel reports that on November 18, 2025, B of A Securities maintained coverage of Acumen Pharmaceuticals (NasdaqGS:ABOS) ...
You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
A North Wales pharmaceutical manufacturer backed by the Development Bank of Wales is accelerating its global expansion by launching two new products and unveiling plans to extend its global ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
West Pharmaceutical Services, Inc. ( WST) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST ...
On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...
PRNewswire/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing patients with rare diseases access to orphan drugs. Medunik ...
US Trade Deal Forces Reckoning For Swiss Pharma Powerhouse. Swiss pharmaceutical companies are planning massive investments in research and manufacturing in the United States as part of a deal to ...
Can UK science really spawn a $1-trillion company? That’s not to downplay the successes. The United Kingdom is ranked fourth ...
In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback